Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.003 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |